bims-micgli Biomed News
on Microglia
Issue of 2026–03–08
39 papers selected by
Matheus Garcia Fragas, Universidade de São Paulo



  1. Proc Natl Acad Sci U S A. 2026 Mar 10. 123(10): e2516774123
      The prevailing view frames microglia and macrophages as guardians against amyloid beta (Aβ) accumulation in Alzheimer's disease (AD). Here, we overturn this paradigm by demonstrating that human phagocytic cells, including differentiated THP-1 macrophages and hESC-derived microglia, are not merely passive responders but active producers of extracellular, seeding-competent Aβ42 fibrils, the amyloid species most strongly linked to parenchymal plaque formation and neurodegeneration. These cell-generated aggregates differ structurally and functionally from synthetic fibrils, displaying enhanced seeding and tau cross-seeding activity in biosensor models. Notably, Aβ42 fibril formation in this system requires active cellular processes and is exacerbated by loss of Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), a major AD risk gene. Transcriptomic profiling reveals an early inflammatory response resembling microglial states observed in human AD models. Together, these findings support emerging evidence from in vivo studies that macrophages and microglia can influence amyloid seeding and introduce a human-relevant in vitro platform to explore how Aβ aggregation intersects with innate immune function and genetic risk. Our results reinforce the concept that microglia may play a dual role in AD, acting both as responders and inadvertent facilitators of amyloid assembly, with implications for early therapeutic intervention.
    Keywords:  Ab42; Alzheimer’s disease; TREM2; microglia
    DOI:  https://doi.org/10.1073/pnas.2516774123
  2. Science. 2026 Mar 05. 391(6789): eads3972
      Alzheimer's disease (AD) is the leading cause of dementia and is characterized by progressive amyloid accumulation followed by tau-mediated neurodegeneration. Despite advances in anti-amyloid immunotherapies, important limitations remain, highlighting the need for new therapeutic strategies. Here, we introduce anti-amyloid chimeric antigen receptors expressed in astrocytes (CAR-A) and validate their function in vitro. We show that two CAR-A designs reduce amyloid and associated pathology after plaque formation and prevent early plaque deposition in vivo. Single-nucleus RNA sequencing shows that CAR-A treatment induces a distinct glial response to amyloid pathology involving coordinated activity of astrocytes and microglia. Each construct additionally elicits distinctive, receptor-specific effects in astrocytes or microglia. Together, these findings support the therapeutic potential of CAR-A as a disease-modifying strategy for AD.
    DOI:  https://doi.org/10.1126/science.ads3972
  3. Sci Adv. 2026 Mar 06. 12(10): eaeb2628
      Axon degeneration underlies clinical deficits in traumatic injuries and neurodegenerative disease. It is not clear how myelinating oligodendrocytes are directly affected by or respond to axon injury and loss. Here, we combined intravital imaging with laser axotomy or single neuron ablation to determine the longitudinal responses by oligodendrocytes that myelinate the degenerating axon. We find that while axons rapidly degenerate, myelin sheaths devoid of axon can persist for weeks. These remaining myelin sheaths lose compaction and slowly shrink. Local to the injury, oligodendrocyte homeostasis is largely maintained, with only a brief change in myelin sheath structural plasticity. After neuron ablation and axotomy, clearance of axon debris is delayed if the axon is myelinated. However, longitudinal imaging of microglia revealed only rare microglial engagement with injured axons, regardless of myelination status. Likewise, microglia did not engage with de-axoned myelin sheaths. These findings highlight the stability of myelinating oligodendrocytes and provide insight into homeostatic neuroglia responses following injury.
    DOI:  https://doi.org/10.1126/sciadv.aeb2628
  4. Nature. 2026 Mar 05.
      
    Keywords:  Alzheimer's disease; Brain; Neurodegeneration
    DOI:  https://doi.org/10.1038/d41586-026-00747-x
  5. Neuron. 2026 Mar 04. pii: S0896-6273(26)00088-7. [Epub ahead of print]114(5): 791-794
      MS4A4A and MS4A6A are microglia-expressed genes linked to Alzheimer's disease risk. In this issue of Neuron, Rosner et al.1 show that these proteins cooperatively restrain TREM2 signaling, dampening protective microglial responses and highlighting MS4A inhibition as a potential strategy to rejuvenate the brain's innate immune system in Alzheimer's disease.
    DOI:  https://doi.org/10.1016/j.neuron.2026.02.005
  6. J Clin Invest. 2026 Mar 02. pii: e196137. [Epub ahead of print]136(5):
      N-acetyl-l-leucine (NALL), a derivative of the branched-chain amino acid leucine, has shown therapeutic potential for neurodegenerative diseases, including in prodromal stages of Parkinson's disease (PD). However, the mechanism of its protective effects has been largely unknown. Using human induced pluripotent stem cell-derived dopaminergic neurons from patients carrying GBA1, LRRK2, or VPS35 mutations, as well as from sporadic PD cases, we found that NALL treatment markedly reduced Ser129 phosphorylated α-synuclein (pS129-syn). Discovery-based proteomic analysis revealed that NALL treatment upregulated lysosomal, mitochondrial, and synaptic proteins without inducing cytotoxicity. The reduction of pS129-syn was dependent on serine protease HTRA1, which was robustly induced by NALL. Moreover, NALL increased the expression of wild-type parkin in mutant dopaminergic neurons, leading to increased glycosylated dopamine transporter, elevated synaptic membrane-associated synaptojanin-1, and accelerated synaptic vesicle endocytosis, suggesting improved synaptic function. Furthermore, in LRRK2R1441C knockin mice, NALL administration decreased pS129-syn, elevated parkin levels, and ameliorated dopamine-dependent motor learning deficits. These findings highlight the therapeutic potential of NALL for PD by its protective effects on α-synuclein pathology and synaptic function in vulnerable dopaminergic neurons.
    Keywords:  Cell biology; Neurodegeneration; Neuroscience; Parkinson disease
    DOI:  https://doi.org/10.1172/JCI196137
  7. Mol Psychiatry. 2026 Mar 06.
      Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface transmembrane receptor from the TREM receptor family, predominantly expressed on the microglia in the central nervous system (CNS). TREM2-initiated signaling plays a crucial role in regulating neuroinflammation and neurodegeneration, particularly in the context of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), through the activation of downstream signaling pathways and transcriptional regulation of relevant genes. In this review, we aim to provide a concise review of the role and mechanistic implications of TREM2 in neurodegeneration and neuroinflammation, with a specific focus on AD and PD. We will discuss the most recent preclinical studies to highlight current advancements in the field. This review is intended to support both basic researchers and clinicians by enhancing their understanding of microglial function in the pathophysiology of AD and PD, as well as its role in neuroinflammation and neurodegeneration. Ultimately, we hope this contribution will pave the way for new discoveries and the development of potential therapeutic interventions.
    DOI:  https://doi.org/10.1038/s41380-026-03505-7
  8. Nat Commun. 2026 Mar 03. pii: 2116. [Epub ahead of print]17(1):
      Alzheimer's disease (AD) brains have variable neuropathologic and biochemical changes. Capturing epigenetic factors associated with this variability can reveal novel biological insights into AD pathophysiology. Here, we conduct an epigenome-wide association study of DNA methylation in 472 AD brains with neuropathologic and biochemical brain protein levels core to AD pathogenesis. Using a novel regional methylation (rCpGm) approach, we identify 5478 significant associations, 99.7% of which associate with tau biochemical measures, and 93 concordant associations in external datasets. Transcriptome-methylome integration reveals enrichment in oligodendrocyte genes, including known AD risk gene BIN1, myelination genes MYRF, MBP and MAG previously implicated in AD, and novel genes like LDB3. Further characterization of these perturbations in independent AD and primary tauopathy datasets highlights consistent tau-related associations. In summary, we uncover the integrative epigenomic landscape of AD, demonstrate tau-related oligodendrocyte gene perturbations as a common potential pathomechanism across tauopathies and share findings via our Multiomic Atlas.
    DOI:  https://doi.org/10.1038/s41467-026-68864-9
  9. J Neurochem. 2026 Mar;170(3): e70398
      Tissue-nonspecific alkaline phosphatase (TNAP) has emerged as a crucial regulator of neuronal circuit formation and maintenance; however, the complexities of its sex- and cell type-specific roles within microglia remain largely unexplored. To address this critical knowledge gap, this study examined how TNAP deficiency differentially affects microglial morphology, function, and signaling in both male and female mice, and investigated its broader implications for neurodevelopment and disease susceptibility. Using Alpl+/+ (wild-type) and Alpl-/- (TNAP knockout) mice, we conducted behavioral assessments at postnatal Days 13-14 to evaluate early neurobehavioral outcomes. Microglia were subsequently isolated for molecular, metabolic, and morphological analyses. TNAP-deficient mice of both sexes exhibited profound physiological deficits, including stunted growth and significant sensorimotor impairments, confirming effective TNAP knockout and indicating that systemic TNAP loss affects multiple cell types beyond microglia. At the cellular level, TNAP loss induced notable morphological changes in microglia, characterized by enlarged cell soma and shortened processes, hallmarks of microglial activation. Molecular profiling revealed upregulation of neuroinflammatory and phagocytic markers, implicating TNAP as a modulator of the innate immune response. Furthermore, metabolic analyses uncovered a dramatic shift in tryptophan-kynurenine metabolism, with increased quinolinic acid production signifying a transition to a neurotoxic, pro-inflammatory state. Additionally, TNAP-deficient microglia displayed extensive dysregulation in purinergic signaling pathways, exemplified by increased expression of key purinergic receptors, and acquired a senescent phenotype evidenced by elevated canonical senescence gene expression. Given the influence of TNAP deficiency on multiple cell populations, some observed microglial phenotypes may result from altered intercellular signaling or indirect effects. To delineate cell-autonomous effects, siRNA-mediated TNAP knockdown was performed in primary microglia isolated from wild-type (WT) mice. TNAP depletion modulated inflammatory responses, suggesting an intrinsic role for TNAP in microglial regulation; however, these effects may not fully recapitulate the extent of deficiency observed in vivo. Overall, TNAP emerges as a key modulator of microglial structure and function, with its dysfunction potentially increasing susceptibility to neurodevelopmental and neurodegenerative disorders. This highlights the potential of TNAP as a therapeutic target for central nervous system health and disease.
    Keywords:  Hypophosphatasia; TNAP; inflammation; kynurenine pathway; microglia; phagocytosis; senescence
    DOI:  https://doi.org/10.1111/jnc.70398
  10. J Clin Invest. 2026 Mar 02. pii: e202688. [Epub ahead of print]136(5):
      Organized adaptive immunity can emerge in the CNS under specific inflammatory and stromal conditions. The study by Yang et al. in this issue of the JCI reports that experimental ischemic stroke induced germinal center-like B cell follicles through microglial MIF-CD74/CXCR4 signaling and in situ B cell proliferation, promoting chronic neuroinflammation. These findings align with a growing body of evidence that the brain and meninges can support ectopic lymphoid structures in multiple sclerosis, during aging, and in certain gliomas. This Commentary integrates these observations to highlight shared principles, disease-specific outcomes, and unresolved questions regarding the identity and function of lymphoid aggregates in the CNS.
    DOI:  https://doi.org/10.1172/JCI202688
  11. Physiology (Bethesda). 2026 Mar 06.
      Microglia are the major resident immune cells in the central nervous system (CNS). They emerge at very early stages of brain development and subsequently expand and persist through self-renewal within the CNS. As a result, microglial behaviors are profoundly shaped by the CNS microenvironment, enabling them to meet the unique demands of neural tissue and to cope with CNS stresses. Neurotransmitters are the primary chemical messages that are conveyed between neurons; however, glia cells, including microglia, are now known to express a wide array of neurotransmitter receptors as well. This positions neurotransmitters as a fundamental mode of communication among most CNS cells. Despite this, the significance of neurotransmitter signaling in microglia biology and function remain elusive. Research studies have begun to unravel the repertoire of neurotransmitter receptors expressed by microglia, the signaling pathways they engage, and the consequences for brain physiology and pathology. These advances have raised new questions and marked the beginning of a new era in neuron-microglia research. In this review, we summarize the latest discoveries concerning neurotransmitter receptors in microglial biology and CNS diseases, and we also discuss future perspectives, including potential clinical applications.
    Keywords:  autonomic nervous system; microglia; neurodegenerative disease; neurotransmitter receptor
    DOI:  https://doi.org/10.1152/physiol.00030.2025
  12. Mol Neurobiol. 2026 Mar 04. pii: 483. [Epub ahead of print]63(1):
      Cerebral ischemia/reperfusion (I/R) injury triggers potent neuroinflammatory responses, in which microglial activation and dysregulated phagocytosis may contribute to neuronal damage. Extracellular cold-inducible RNA-binding protein (eCIRP), a damage-associated molecular pattern, has been implicated in postischemic inflammation; however, its role in regulating microglial phagocytosis remains poorly understood. This study employed a porcine model of cardiac arrest/reperfusion (CA/R) and a mouse cellular model of oxygen-glucose deprivation/reoxygenation (OGD/R) in BV2 microglia and N2a neuron to investigate the role of the eCIRP-TREM2 signaling in microglial activation. We evaluated protein expression and direct interaction between CIRP and TREM2 by Western blotting, immunofluorescence, co-immunoprecipitation, and surface plasmon resonance (SPR), while assessing phagocytic activity by fluorescent microsphere uptake and synaptic protein expression assays. Both CA/R and OGD/R conditions significantly elevated the levels of CIRP expression and activation of the TREM2-DAP12-Syk-ERK1/2 signaling. Treatment with recombinant human CIRP (rhCIRP) further increased the expression of microglial activation markers and enhanced phagocytic activity, accompanied by reducing the expression of synaptic proteins. These effects were partially mitigated by CIRBP or TREM2 silencing, or ERK inhibition. Our findings support a novel hypothesis that eCIRP may bind to TREM2 and activate downstream signaling in microglia, enhancing their phagocytic responses in the process of I/R-induced neuronal injury. The eCIRP-TREM2 axis may thus represent a potential therapeutic target for modulating neuroinflammation and preserving neuronal integrity.
    Keywords:  Cardiopulmonary resuscitation; Ischemia-reperfusion injury; Microglial; Phagocytosis; eCIRP
    DOI:  https://doi.org/10.1007/s12035-026-05764-5
  13. Nat Med. 2026 Mar 05.
      Triggering receptor expressed on myeloid cells 2 (TREM2) regulates microglial function and is implicated in Alzheimer's disease (AD) pathogenesis. Here we conducted a phase 2, randomized, double-blind, placebo-controlled trial of a humanized TREM2 agonistic monoclonal antibody in 381 participants with early AD. Participants were randomized (1:1:1:1) to receive AL002 (15 mg kg-1, 40 mg kg-1 or 60 mg kg-1) or placebo intravenously every 4 weeks for 48-96 weeks. AL002 demonstrated sustained target engagement and pharmacodynamic responses in the central nervous system, as demonstrated by reductions in soluble TREM2 and increases in osteopontin in cerebrospinal fluid, respectively. The study did not meet the primary endpoint of change from baseline in the Clinical Dementia Rating-Sum of Boxes score (versus placebo) (least squares mean difference versus placebo (95% confidence interval) at week 96: 15 mg kg-1 -0.31 (-1.61 to 0.98), 40 mg kg-1 0.13 (-1.18 to 1.43) and 60 mg kg-1 -0.17 (-1.49 to 1.15); P > 0.05 from mixed-effects model for repeated measures). The most frequent treatment-emergent adverse events were magnetic resonance imaging changes resembling amyloid-related imaging abnormalities (ARIA). This first trial of a TREM2 agonistic antibody in early AD was negative but provides findings relevant to the study of TREM2 therapeutics and ARIA. ClinicalTrials.gov: NCT04592874 .
    DOI:  https://doi.org/10.1038/s41591-026-04273-1
  14. Science. 2026 Mar 05. 391(6789): 990-991
      Genetically altered astrocytes reduce a cardinal pathological feature of Alzheimer's disease.
    DOI:  https://doi.org/10.1126/science.aef8451
  15. Sci Adv. 2026 Mar 06. 12(10): eaea8940
      In Alzheimer's disease, many surviving neurons with tau pathology contain granulovacuolar degeneration bodies (GVBs), neuron-specific lysosomal structures induced by pathological tau assemblies. This could indicate a neuroprotective role for GVBs; however, the mechanism of GVB formation and its functional implications are elusive. Here, we demonstrate that casein kinase 1δ (CK1δ) activity is required for GVB formation. CK1δ is sequestered in the GVB during this process in an autophagy-dependent manner. We show that neurons with GVBs (GVB+) are resilient to tau-induced impairment of global protein synthesis and are protected against tau-mediated neurodegeneration. GVB+ neurons do not exhibit differential activation of transient translational stress responses but have increased ribosomal content. Unlike neurons without GVBs, GVB+ neurons fully retain the capacity to induce long-term potentiation-induced protein synthesis in the presence of tau pathology. Our results have identified CK1δ as a key regulator of GVB formation that confers a protective neuron-specific stress response to tau pathology. These findings provide opportunities for targeting neuronal resilience in tauopathies.
    DOI:  https://doi.org/10.1126/sciadv.aea8940
  16. Proc Natl Acad Sci U S A. 2026 Mar 10. 123(10): e2530340123
      Neurons are terminally differentiated cells that adapt to maintain stable function over years, despite encountering a wide range of environmental perturbations. In some cases, recovery from perturbation is not shaped by prior exposure; in others, recovery depends on the neuron's perturbation history. A particularly striking form of history-dependent recovery occurs when prior exposure enhances the neuron's ability to recover from future perturbations while leaving baseline activity largely unchanged. Among the many mechanisms that may contribute to such history-dependent improvement in recovery, we investigate one based on the regulation of intrinsic currents. Using a model of activity-dependent homeostasis, we show that improved recovery can be encoded through lasting changes in channel density, while rapid shifts in ion channel voltage-dependence provide immediate compensation during perturbations. We refer to the long-lasting intrinsic trace that accompanies this improved recovery a persistent adaptation. Interestingly, these roles are noninterchangeable: when voltage-dependence evolves slowly and maximal conductances change rapidly, an intrinsic trace is not stored, eliminating persistent adaptation even when improved recovery is preserved.
    Keywords:  activity-dependent regulation; computational model; high potassium; homeostatic plasticity; intrinsic excitability
    DOI:  https://doi.org/10.1073/pnas.2530340123
  17. bioRxiv. 2025 Aug 28. pii: 2025.08.26.671836. [Epub ahead of print]
      T Regulatory T cells (Tregs) from patients with relapsing-remitting multiple sclerosis (RRMS) exhibit impaired suppressive function, yet the underlying molecular mechanisms remain elusive. Single-cell RNA sequencing (scRNAseq) of ex vivo- sorted Tregs from RRMS patients and matched healthy controls (HCs) revealed down-regulation of type I IFN (IFN) and IL-27 signaling pathways in RRMS Tregs. These Tregs showed reduced expression of IFN-stimulated genes (ISGs) ( ISG15, MX1, IFITM1, IFI44L, OAS1 ), as well as key mediators of Treg suppressive function ( LGALS3, CD81, FCRL3, CD7, CSTB ), all suggesting a key role of decreased IFN signaling in RRMS Treg dysfunction. To therapeutically target IFN signaling pathways and improve Treg suppressive functions, we used cGAMP-loaded microparticles (MPs) to activate the stimulator of IFN genes (STING) in experimental autoimmune encephalomyelitis (EAE). cGAMP-MP treatment ameliorated EAE via induction of Tregs expressing IL-27R, IL-10, TGF-b, and Granzyme B. This effect was abolished in Treg-specific IL-27R (Treg ΔIl27ra ) knockout mice, confirming that IL-27 signaling is essential for Treg suppression. In vitro IL-27 stimulation of RRMS-derived Tregs restored expression of IFN pathway genes ( IRF1, IFNGR, IFI16 ) and Treg suppressive genes ( ICOS, IKZF3, IL7R, TIGIT ). Thus, we propose that IL-27 pre-stimulation may restore their suppressive function and migration (via CCR6, CCR7, S100A11 and S1PR4 ) to the central nervous system (CNS) in future clinical trials.
    Significance: Several studies have reported a role for type I IFN and IL-27 signaling in the induction of suppressive Tregs in autoimmune diseases. We report that RRMS Tregs have decreased expression of type I IFN and IL-27 signalling-related genes in comparison to HCs. The animal model of MS (EAE) was successfully treated with cGAMP-MPs, which, via induction of type I IFN, IL-27 and IL-10, restored Treg suppressive function. A scRNAseq study of Tregs from MS patients revealed that IL-27 in vitro stimulation normalized the expression of type I IFN genes and Treg suppressive genes. We propose that IL-27 pre-treatment may enhance Treg suppressive function and migration to the CNS in future clinical trials.
    DOI:  https://doi.org/10.1101/2025.08.26.671836
  18. J Exp Med. 2026 Apr 06. pii: e20251761. [Epub ahead of print]223(4):
      Proper organization of the enteric nervous system (ENS) is critical for normal gastrointestinal (GI) physiology. Inflammatory bowel disease (IBD) disrupts key GI functions, including bowel motility. However, in many IBD patients, motility disorders persist even during remission, suggesting an irreversible ENS defect secondary to IBD. Here, we show that postinflammatory GI motility dysfunction arises from structural remodeling of the ENS, driven by a combination of neuronal loss and neurogenesis. During mucosal inflammation, enteric neurons upregulate CCL2 expression, facilitating the recruitment of monocytes into the myenteric plexus within the intestinal muscle. Monocyte-derived macrophages infiltrate the myenteric ganglia, contributing to excessive ENS remodeling and postinflammatory motility dysfunction. This neuroimmune axis is counterbalanced by a hypoxia-induced stress response in enteric neurons mediated by HIF1α. Enhancing the neuron-intrinsic hypoxia pathway limits ENS remodeling and preserves motility. In summary, this study presents a mechanistic model of postinflammatory GI motility dysfunction and proposes a therapeutic strategy to maintain ENS integrity and function during inflammation.
    DOI:  https://doi.org/10.1084/jem.20251761
  19. Mol Neurobiol. 2026 Feb 28. pii: 476. [Epub ahead of print]63(1):
      Traumatic brain injury (TBI) causes lasting neurological impairments, particularly learning and memory deficits associated with hippocampal damage. Emerging evidence suggests that hippocampal vulnerability may be linked to bioenergetic dysfunction, though its role remains poorly defined. A deeper understanding of post-TBI metabolic disturbances and their association with pathological outcomes could reveal novel therapeutic targets. In this study, we conducted functional bioenergetic assessments and multi-omics analyses on hippocampal slices using a mouse controlled cortical impact model of TBI. Seahorse analysis revealed a significant reduction in mitochondrial oxidative phosphorylation in dentate gyrus (DG) slices at day 1 (acute phase), which recovered by day 7 (subacute phase) post-TBI. Metabolomic profiling revealed acute impairments in purine nucleotide, glucose, amino acid, and fatty acid metabolism, most of which normalized by day 7. Isotope tracing indicated enhanced octanoate-derived fatty acid oxidation (FAO) in DG slices at day 7 post-TBI. Proteomics confirmed suppressed purine metabolism at day 1 across hippocampal subregions, while FAO remained preserved at day 1 and became significantly elevated by day 7, suggesting a compensatory metabolic adaptation. Administration of sodium octanoate, a medium-chain fatty acid, at 1 h post-TBI enhanced mitochondrial respiration at 24 h, reduced microglial counts at 48 h, and attenuated neurodegeneration by day 3. These findings identify FAO enhancement as a promising metabolic strategy to restore hippocampal bioenergetics and promote neuroprotection following TBI.
    Keywords:  Bioenergetics dysfunction; Fatty acid oxidation; Hippocampus; Sodium octanoate; Traumatic brain injury
    DOI:  https://doi.org/10.1007/s12035-026-05767-2
  20. J Clin Invest. 2026 Mar 02. pii: e196905. [Epub ahead of print]136(5):
      Neuroinflammation, encompassing both innate and adaptive immune responses, plays a crucial role in ischemic stroke. Although B lymphocytes are central to adaptive immunity, their contributions to ischemic stroke remain poorly understood. Here, we demonstrated that B lymphocytes accumulate in ischemic lesions, forming germinal center-like structures at the later stage after stroke, which mainly depended on in situ proliferation. This accumulation correlated with worsened neuroinflammation and ischemic injury, whereas B cell depletion reduced chronic brain damage during stroke. Mechanistically, microglia recruited B cells into ischemic lesions through MIF-CD74/CXCR4 signaling during the early phase of stroke, while IFN-related pathways in B cells further drove neuroinflammation and brain injury. Targeting these pathways markedly alleviated cerebral ischemia and inflammation. Our findings shed light on the role of B lymphocytes in stroke pathology and suggest promising new avenues for therapeutic intervention.
    Keywords:  B cells; Immunology; Neuroscience
    DOI:  https://doi.org/10.1172/JCI196905
  21. Cell. 2026 Mar 04. pii: S0092-8674(26)00163-7. [Epub ahead of print]
      Lewy bodies, a pathological hallmark of Parkinson's disease, are α-synuclein-enriched cytoplasmic inclusions that drive progressive neurodegeneration. A long-standing yet unmet goal has been the visualization of α-synuclein (α-Syn) inclusions in live brain and measurements of their pathological effects on individual neurons. Here, we developed genetically encoded reporters and knock-in mouse lines to achieve this goal. The reporters exhibited a 5-fold increase in fluorescence upon incorporation into α-Syn inclusions. They reliably reflected α-Syn inclusion propagation in the cortex of awake mice. Coupled with Ca2+ imaging and whole-cell recording, the reporters enabled measurement of the pathological effects of inclusions on neuronal activity and synaptic function. They could be selectively targeted to specific neuronal subtypes, facilitating measurement of the pathological effects on transcriptomes and metabolomes at the single-cell level. In live-cell imaging, the reporters helped identify inhibitors of α-Syn inclusion formation. Collectively, these genetically encoded reporters support multiple applications to study α-Syn inclusions in live brain.
    DOI:  https://doi.org/10.1016/j.cell.2026.01.035
  22. Sci Immunol. 2026 Mar 06. 11(117): eaeg7147
      EBV enables B cells to bypass death in the CNS, linking viral infection to autoimmune demyelination in multiple sclerosis.
    DOI:  https://doi.org/10.1126/sciimmunol.aeg7147
  23. J Neuroimmunol. 2026 Feb 18. pii: S0165-5728(26)00042-1. [Epub ahead of print]415 578894
      Interferon regulatory factor 8 (Irf8) is a transcription factor expressed only in the microglia in the brain and directs the expression of many genes that serve microglial functions. This report investigates the role of Irf8 in microglia during the progression of hypertensive intracerebral hemorrhage (ICH). L-NAME and angiotensin II initiated the ICH mouse model after stereotactic injection of knockdown and overexpression vectors. Inflammatory responses were induced in the mouse microglia cell line BV-2 using lipopolysaccharide (LPS), and lentiviral infection was conducted to manipulate gene expression. Irf8 was significantly overexpressed in the brain tissues of ICH mice and LPS-induced BV-2 cells. Downregulation of Irf8 hampered microglial M1 polarization and the inflammatory response and partially alleviated limb dysfunction caused by neurological impairment resulting from ICH. Irf8 interacted with the signal transducer and activator of transcription 1 (Stat1), thus mediating the transcriptional activation of Stat1 on tripartite motif-containing protein 5 (Trim5) in microglia. Overexpression of Trim5 reversed the inhibitory effect of sh-Irf8 on the inflammatory response in microglia and exacerbated cerebral hemorrhage in ICH mice. Thus, it was suggested that Irf8 overexpression activated the Stat1/Trim5 axis and mediated a microglial proinflammatory phenotype, thereby exacerbating hypertensive ICH.
    Keywords:  Hypertensive intracerebral hemorrhage; Irf8; Microglia; Stat1; Trim5
    DOI:  https://doi.org/10.1016/j.jneuroim.2026.578894
  24. Nat Commun. 2026 Mar 06.
      Aging is a primary risk factor for chronic diseases, with cellular senescence as an effective target to delay, prevent or alleviate age-related disorders. Here we report in vitro screening outputs from a natural medicinal agent library, wherein dihydromyricetin, a natural flavonoid, showed senotherapeutic potential. Dihydromyricetin protects senescent fibroblasts against further DNA damage and attenuates the senescence-associated secretory phenotype, acting as a senomorphic agent. Proteomics suggests that dihydromyricetin promotes nuclear translocation of peroxiredoxin 2 (PRDX2) to facilitate DNA repair in senescent cells. In prematurely aged mice, dihydromyricetin administration mitigates tissue aging and age-related physiological decline. In anticancer regimens, dihydromyricetin improves outcomes of chemotherapy. However, dihydromyricetin demonstrates senolytic activity against senescent microglial cells, whose basal PRDX2 expression remains low, by impairing mitochondrial function to promote apoptosis. In mice developing Alzheimer's disease, dihydromyricetin eliminates senescent microglial cells from amyloid β-protein plaques and alleviates neurodegenerative symptoms. Together, our study proposes dihydromyricetin as a natural senotherapeutic agent for mitigating age-related morbidities, including but not limited to cancers and Alzheimer's disease.
    DOI:  https://doi.org/10.1038/s41467-026-70302-9
  25. Cell Metab. 2026 Mar 03. pii: S1550-4131(26)00045-8. [Epub ahead of print]38(3): 449-451
      In a recent issue of Cell, Song et al.1 show that the pentose phosphate pathway (PPP) plays dual roles as a metabolic checkpoint. Spatial enrichment of PPP in peripheral nerves maintains mechanosensation homeostasis via NADPH-dependent redox balance, shifting to promote axon regeneration after injury by providing ribose-5-phosphate for RNA synthesis.
    DOI:  https://doi.org/10.1016/j.cmet.2026.02.002
  26. Nat Commun. 2026 Mar 03.
      Proteins undergo phase separation to form membraneless condensates that spatially organize biomolecular interactions. These condensates can support cellular physiology or instigate pathological protein aggregation. Tau and α-synuclein (αSyn) are neuronal proteins that form heterotypic Tau:αSyn condensates associated with physiological and pathological processes. Tau and αSyn regulate microtubules, but also misfold and co-deposit in aggregates linked to neurodegenerative disease, highlighting the ambivalent impact of Tau:αSyn condensation in health and disease. Here, we show that Tubulin modulates Tau:αSyn condensates by promoting microtubule interactions and inhibiting homotypic and heterotypic pathological oligomers. In the absence of Tubulin, Tau-driven condensation accelerates formation of pathogenic Tau:αSyn heterodimers and amyloid fibrils. Tubulin partitioning into condensates promotes microtubule polymerization and prevents Tau and αSyn oligomerization. We identify distinct Tau and αSyn structural states in pathological Tubulin-absent versus physiological Tubulin-rich condensates. In neuronal models, microtubule loss drives pathological oligomer formation and neurite loss, whereas inducible Tau condensation stabilizes microtubules.
    DOI:  https://doi.org/10.1038/s41467-026-69618-3
  27. Sci Adv. 2026 Mar 06. 12(10): eaea2882
      Spinal cord injury (SCI) triggers complex cellular and extracellular responses that disrupt neuronal connectivity and hinder repair. While mammals have limited regenerative abilities, zebrafish achieve functional recovery through coordinated neuroprotection and plasticity. Here, we examined how structural and functional adaptations of damaged spinal neurons interact with extracellular matrix (ECM) dynamics during regeneration in adult zebrafish. We found that injured neurons undergo reversible changes in cellular properties and synaptic input, mediated mainly by glutamatergic signaling. These modifications coincide with a transient ECM reorganization marked by increased deposition of chondroitin sulfate proteoglycans (CSPGs). Enzymatic CSPG degradation paradoxically partially impaired long-term axonal regrowth and locomotor recovery. Thus, CSPG-rich ECM exerts a dual role: initially restricting plasticity but subsequently supporting structural stabilization and regeneration. Our findings highlight a temporally coordinated interplay between neuronal excitability, synaptic remodeling, and ECM reorganization as key determinants of spinal cord repair, offering mechanistic insights for enhancing nervous system regeneration.
    DOI:  https://doi.org/10.1126/sciadv.aea2882
  28. Nat Aging. 2026 Mar 02.
      Exercise confers cognitive benefits in Alzheimer's disease (AD), yet the underlying mechanisms remain incompletely understood. Skeletal muscle functions as an endocrine organ that secretes myokines which affect the homeostasis of extra-muscular organs, including the brain. Here we found that swimming exercise promotes secretion of skeletal muscle-derived extracellular vesicles (SKM-EVs), which are subsequently taken up via pinocytosis by microglia. Gain-of-function and loss-of-function experiments showed that exercise-induced SKM-EVs induce polarization of disease-associated microglia and enhance the clearance of amyloid-beta plaques. Furthermore, miR-378a-3p was identified as a key microRNA cargo in SKM-EVs, regulating lipid metabolism in disease-associated microglia by targeting p110α. Importantly, administration of extracellular vesicles derived from miR-378a-overexpressing myotubes alleviated cognitive impairment in AD mice. Together, our findings demonstrate that exercise-induced SKM-EVs could serve as a myokine, mediating communication from skeletal muscle to the brain, providing a potential exercise-mimicking therapeutic strategy for AD.
    DOI:  https://doi.org/10.1038/s43587-026-01075-5
  29. Sci Adv. 2026 Mar 06. 12(10): eaeb3345
      Memory CD4+ T cells are central to long-term immunity, yet their persistence in the absence of antigen remains controversial. Lifelong immunity following cutaneous leishmaniasis is primarily mediated by CD4+ T cells, but whether persistent parasites are required for sustaining this immunity has not been empirically established. Using a nonpersistent Leishmania major strain (dhfr-ts-deficient), we demonstrate that loss of antigen leads to a decline in Leishmania-specific CD4+ T cells and susceptibility to reinfection. To elucidate the mechanism, we developed Leishmania phosphoenolpyruvate carboxykinase (PEPCK)-specific CD4+ T cell receptor transgenic (PEG) mice, enabling precise tracking of Leishmania-specific memory CD4+ T cells. Both in vitro and in vivo-generated memory PEG cells progressively declined in the absence of antigen, independent of major histocompatibility complex II expression. Mice infected with PEPCK antigen-deficient L. major failed to sustain recall responses and secondary immunity. These findings in a L. major model system argue that persistent antigen may be indispensable for maintaining memory CD4+ T cells and ensuring durable immunity against chronic infections.
    DOI:  https://doi.org/10.1126/sciadv.aeb3345
  30. Nat Commun. 2026 Mar 04. pii: 2161. [Epub ahead of print]17(1):
      Herbivory has evolved multiple times during mammalian diversification, playing a key role in the success of this globally distributed clade. A central metabolic challenge for herbivores is the detoxification of glyoxylate. The enzyme alanine:glyoxylate aminotransferase (AGT) converts glyoxylate to glycine, preventing the formation of harmful calcium oxalate crystals. AGT localizes to mitochondria and peroxisomes based on the mitochondrial targeting sequence (MTS) and the peroxisomal targeting signal (PTS1), respectively. While most studies focused on MTS, MTS variation alone does not fully explain AGT localization patterns. To assess the relative importance of the PTS1 motif, we combined comparative sequence analyses with functional assays. We find that multiple herbivorous lineages underwent independent mutations resulting in disrupted or truncated MTS regions, whereas the PTS1 motif remains functional. Immunofluorescence assays revealed more efficient peroxisomal localization of AGT in herbivores, with PTS1 often overriding mitochondrial signals even when the MTS is intact. Additionally, transcriptomic analyses show that several herbivorous lineages preferentially use downstream transcriptional start sites, producing AGT isoforms lacking the MTS. Together, our findings reveal a central role of AGT peroxisomal targeting in evolution of plant-based diets, and demonstrate how increased targeting efficiency has evolved convergently via the interplay of transcriptional regulation and targeting signals.
    DOI:  https://doi.org/10.1038/s41467-026-70246-0
  31. J Immunol. 2026 Feb 09. pii: vkaf353. [Epub ahead of print]215(2):
      Naïve CD8+ T-cell activation needs to overcome a signaling threshold to initiate the resulting program of T cell proliferation and differentiation. While the strength of T-cell receptor (TCR) signaling and co-stimulation are known to dictate T-cell responsiveness, the role of other factors that determine strength of signal is not well studied. Glucocorticoid-induced leucine zipper (GILZ) is a regulatory protein that serves to dampen activation signals in several leukocyte populations. Here we demonstrate that GILZ is highly expressed in murine naïve CD8+ T cells and downregulated with activation. GILZ deficiency increased accumulation of antigen-specific CD8+ T-cell responses in a mouse model of influenza A virus infection, and this correlated with greater responsiveness to low-affinity ligands. GILZ-deficient CD8+ T cells were able to better engage optimal effector transcriptional programs at lower signaling thresholds, highlighting GILZ as a key checkpoint for naïve CD8+ T cell activation. Importantly, GILZ deficiency did not impact memory T cell formation or recall responses to influenza A virus infection. These data demonstrate that GILZ acts as an important naïve CD8+ T cell checkpoint by establishing a threshold for initial activation. Modulation of GILZ could be beneficial in improving CD8+ T cell responses against low-affinity ligands, particularly like those found in the context of tumor antigens.
    Keywords:  CD8+ T cell; T-cell memory; influenza virus; transcription factor
    DOI:  https://doi.org/10.1093/jimmun/vkaf353
  32. Cell Metab. 2026 Mar 03. pii: S1550-4131(26)00046-X. [Epub ahead of print]38(3): 447-448
      In a recent issue of Cell, Gu et al. find that regulatory T (Treg) cells metabolize tumor-derived ammonia via the urea cycle and spermine synthesis, promoting immunosuppression through PPARγ-dependent oxidative phosphorylation. Inhibition of tumor glutamine metabolism reduces ammonia levels and overcomes Treg cell-mediated resistance to anti-PD-1 therapy.
    DOI:  https://doi.org/10.1016/j.cmet.2026.02.003
  33. Proc Natl Acad Sci U S A. 2026 Mar 10. 123(10): e2526577123
      Hemolysis is associated with the release of damage-associated molecular patterns, including free heme and extracellular DNA (ecDNA). Using several mouse models of bleeding anemia and hemolysis, we demonstrate a significant increase in plasma ecDNA, independent of neutrophil extracellular trap formation. This ecDNA forms G-quadruplex (G4) structures, which we detected in both mice and patients with systemic lupus erythematosus. Catalytic complexes (DNAzymes) formed by G4 ecDNA and heme drive oxidative stress, tissue injury, and inflammation. In anemic mice lacking deoxyribonuclease 1L3 (DNase1l3-/-), we found elevated polynucleosomal ecDNA in the plasma, reduced expression of the heme-degrading enzyme heme oxygenase-1 in macrophages, but also increased plasma creatinine, renal iron accumulation, and complement C3 deposition along elevated apoptosis and DNA damage. ecDNA isolated from these mice also triggered toll-like receptor 9-dependent inflammatory responses in vitro and in vivo. In summary, these findings suggest that concurrent release of heme and ecDNA during hemolysis promotes inflammation and tissue damage, contributing to lupus pathogenesis.
    Keywords:  cell-free DNA; hemolysis; iron deposition; lupus; nephritis
    DOI:  https://doi.org/10.1073/pnas.2526577123
  34. Sci Adv. 2026 Mar 06. 12(10): eaed3579
      Cells have evolved organelle-specific responses to maintain protein homeostasis (proteostasis). During proteostatic stress, mitochondria down-regulate translation and enhance protein folding, yet the underlying mechanisms remain poorly defined. Here, we used cryo-electron tomography to observe the structural consequences of mitochondrial proteostatic stress within human cells. We detected protein aggregates within the mitochondrial matrix, accompanied by a marked remodeling of cristae architecture. Concomitantly, the number of mitochondrial ribosome complexes was significantly reduced. Mitochondrial Hsp60 (mHsp60), a key protein folding machine, underwent major conformational changes to favor complexes with its co-chaperone mHsp10. We visualized the interactions of mHsp60 with native substrate proteins and determined in vitro mHsp60 cryo-electron microscopy structures enabling nucleotide state assignment of the in situ structures. These data converge on a model of the mHsp60 functional cycle and its essential role in mitochondrial proteostasis. More broadly, our findings reveal structural mechanisms governing mitochondrial protein biosynthesis and their remodeling under proteostatic stress.
    DOI:  https://doi.org/10.1126/sciadv.aed3579